Colossal Biosciences has raised $200 million in Series C funding, bringing its total investment to $435 million with a valuation of $10.2 billion. Backed by high-profile investors from Hollywood, tech, and finance, the company is advancing de-extinction and species preservation through cutting-edge technologies in genetic engineering, AI, and biotechnology.